Clinical Trial Update: Raltitrexed Concurrent With Radiotherapy for Elderly Chinese Patients With Squamous Cell Carcinoma of Esophagus [Phase 2]

View source ↗

Summary

Phase 2 trial update examining raltitrexed concurrent with radiotherapy in elder Chinese patients with esophageal squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Raltitrexed (Raltitrexed)

Snippet

Sponsor: Huai'an First People's Hospital | Conditions: Esophagus Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN